(Q38499432)

3 September 2017

Mortality and prostate cancer risk in 19,598 men after surgery for benign prostatic hyperplasia (English)

1 reference

3 September 2017

1 reference

1

Holman CD

1 reference

3 September 2017

Wisniewski ZS

2

1 reference

3 September 2017

Semmens JB

series ordinal

3

1 reference

3 September 2017

Rouse IL

series ordinal

4

1 reference

3 September 2017

Bass AJ

series ordinal

5

1 reference

3 September 2017

1 July 1999

1 reference

3 September 2017

1 reference

3 September 2017

84

1 reference

3 September 2017

37-42

1 reference

3 September 2017

1

1 reference

A population-based study of prostatectomy: outcomes associated with differing surgical approaches

3 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Mortality and reoperation followingprostatectomy: Outcomes in a medicare population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota: 1980-87. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Deaths and complications following prostatectomy in 1400 men in the northern region of England. Northern Regional Prostate Audit Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Mortality after prostatectomy: selection and surgical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Mortality after transurethral and open prostatectomy in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Does transurethral resection of a clinically benign prostate gland increase the risk of developing clinical prostate cancer? A 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

A computer program package for relative survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Stratification by a multivariate confounder score

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

Benign Prostatic Hyperplasia: Antecedents and Natural History

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00123.X

10.1046/J.1464-410X.1999.00123.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference